GlassScriptPhysician profile
Richard Dittrich
NPI 1528030327
$8,817.82
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,318 · 2020: $1,419 · 2021: $80.72.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $8,392.27 | 2019-2020 | |
| Galderma Laboratories, L.P. | $116.14 | 2019 | |
| Therapeuticsmd, INC. | $87.58 | 2019 | |
| Allergan, INC. | $58.14 | 2019 | |
| Abbvie INC. | $47.64 | 2019-2021 | |
| Evofem Biosciences, INC. | $45.80 | 2021 | |
| Amgen INC. | $25.71 | 2019 | |
| Hologic Sales and Service, LLC | $16.34 | 2020 | |
| Avion Pharmaceuticals | $14.32 | 2019 | |
| Millicent US INC | $13.88 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Dittrich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.